药物坚持框架:基于人群的药理动力学方法及其在抗疟疾治疗评估中的应用
Junjie Ding1,2,3, Richard M Hoglund1,2, Joel Tarning1,2,3
1Mahidol Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.
CPT: pharmacometrics & systems pharmacology
|March 26, 2024
概括
使用百分位和贝叶斯方法的新药量学框架可以评估患者对抗疟疾药物的坚持. 百分比方法显示了可接受的预测,特别是当在剂量后的第7天采用piperaquine和第3天采用lumefantrine时.
科学领域:
- 药物指标 (Pharmacometrics) 是一个指标.
- 药物坚持性评估药物坚持性评估
- 抗疟疾药物疗法是一种药物疗法.
背景情况:
- 患者遵守处方药物治疗方案对于治疗疗效至关重要,特别是对于抗疟疾药物.
- 评估在现实环境中的坚持,特别是在特有地区,提出了重大挑战.
- 基于人群的药量计方法为评估遵守提供了潜在的解决方案.
研究的目的:
- 开发和评估一个药量测量框架,以使用百分位和贝叶斯方法来评估患者的坚持.
- 为了比较这两种基于人口的方法在各种坚持情景和影响因素下的预测性能.
- 确定最佳的采样时间和条件,以准确评估像皮佩拉基因和卢梅芬特林这样的抗疟药物的坚持.
主要方法:
- 开发了一个药量测量框架,使用两个基于人口的方法:百分位和贝叶斯式.
- 研究了三种剂量策略:非观察治疗,直接观察第一剂量和直接观察前两剂量.
- 模拟药物度以获得最佳度百分点截止值,并计算粘附场景的后期概率.
主要成果:
- 预测性能受到早期样本采集时间和低个体间变异性的高度影响.
- 百分位数方法的性能与贝叶斯方法的整体依从性预测性能相似或更好.
- 对于第7天的piperaquine和第3天的lumefantrine,可接受的坚持预测 (AUC>0.74) 已实现.
结论:
- 开发的药量测量框架,特别是百分位方法,为评估患者对抗疟疾治疗的坚持提供了可行的工具.
- 通过特定的采样时间,可以实现最佳的依从性评估,从而促进疟疾流行地区的程序性评估.
- 这种方法可以支持公共卫生倡议的实施和监测,以预防和治疗疟疾.
相关概念视频
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
123
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
123
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
69
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
69
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
62
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
62
Model Approaches for Pharmacokinetic Data: Compartment Models
93
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
93
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
38
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
38
Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43


